Corporate Compliance

Other CMS and OIG Issuances

Medicare Insider, April 29, 2008

Want to receive articles like this one in your inbox? Subscribe to Medicare Insider!

CMS issues national coverage decision (NCD) on blood-derived products for treatment of chronic non-healing wounds

On April 22, CMS issued an NCD announcing that the following blood-derived products for the treatment of chronic non-healing wounds will continue to be noncovered:

  • Autologous platelet derived growth factor for the treatment of chronic non-healing cutaneous wounds
  • Autologous platelet rich plasma for the treatment of chronic non-healing cutaneous wounds
  • Treatments using becaplermin, a non-autologous growth factor for chronic non-healing wounds

View the NCD.



Want to receive articles like this one in your inbox? Subscribe to Medicare Insider!

Comments

0 comments on “Other CMS and OIG Issuances

 

Most Popular